Kit ELISA sandwich Interleukin 28A (Hu IL-28A) (human): quantitative determination of Hu IL-28A in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IL-28A.
Kit ELISA sandwich Interleukin 28A (Hu IL-28A) (human): quantitative determination of Hu IL-28A in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IL-28A.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Il-28A belongs to the lambda family of l-IFN, a new family of cytokines within the IL-10 superfamily. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2) and IL-28B (IFN lambda 3), and are also known as III interferons. The lambdas IFN signal by a heterodimer receptor, one subunit, IL-10R2, is shared with other members of the superfamily. The second subunit, IFN lambda R1 or IL-28R alpha, is unique to IFN lambdas. Signalling occurs through the Jak/STAT pathway in the same way as type I IFN (IFN alpha/beta) and activates several of the same genes despite a low sequence homology between cytokines and receptors in both families. Both families of d的IFN have antiviral activity through the induction of antiviral protein production in target cells and the regulation of class I expression in MHC. These proteins also have anti-proliferative and anti-tumour effects, making them a possible alternative to the therapies for alpha-IFN cancer. Unlike Type I IFN, which can stimulate most cells, the response to stimulation of the lambda IFN appears to be limited to dendritic and certain tumour cells due to the limited expression of the IFN lambda R1. Another notable difference is the ability of the stimulation of the IFN lambda to drive dendritic cells to CD4+CD25+FOXP3+ regulatory T cells, suggesting a possible immunoregulatory role.
Sensitivity
Sensitivity of dosage: 15 pg/ml.
Measurement range
Dose range: 13.72-10.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15425043 |
| Specifications |
| Accession number | Q8IZJ0 |
| Dose range | 13.72-10.000 pg/ml |
| Sensitivity of the dosage | 15 pg/ml |
| Calibration range | 15 pg/ml to 10000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Other proteins |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-16, IL-17, IL-18, IL-29, IL-309, IP-10, G |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 282616 |
| Gene symbol(s) | IL-28A,IL28A |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Virology |
| Synonym | IL-28A, IL28A |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHIL28A |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.